<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chromosome 11p15 has attracted considerable attention because of the biological importance of this region to human disease </plain></SENT>
<SENT sid="1" pm="."><plain>Apart from being an important <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor locus showing loss of heterozygosity (LOH) in several adult and <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancers</z:e>, 11p15 has been shown by linkage analysis to harbor the gene(s) for the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Furthermore, the clustering of known imprinted genes in the 11p15.5 region suggests that the target gene may also be imprinted </plain></SENT>
<SENT sid="3" pm="."><plain>However, positional cloning efforts to identify the target genes have been complicated by the large size (approximately 10 Mb) and complexity of LOH at 11p15 </plain></SENT>
<SENT sid="4" pm="."><plain>Here, we have analyzed 94 matched <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">breast tumor</z:e> samples using 17 polymorphic markers that map to 11p15.5-15.4 </plain></SENT>
<SENT sid="5" pm="."><plain>We have defined precisely the location of a <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">breast tumor</z:e> suppressor gene between the markers D11S1318 and D11S4088 (approximately 500 kb) within 11p15.5 </plain></SENT>
<SENT sid="6" pm="."><plain>LOH at this region occurred in approximately 35-45% of <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">breast tumors</z:e> analyzed </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, we have fine-mapped a second, critical region of LOH, that spans the markers D11S1338-D11S1323 (approximately 336 kb) at 11p15.5-p15.4, that is lost in approximately 55-60% of <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">breast tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>There is a striking correlation between the loss of the two 11p loci and the clinical and histopathological features of <z:e sem="disease" ids="C1458155" disease_type="Neoplastic Process" abbrv="">breast tumors</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>LOH at region 1 correlated significantly (P = 0.016) with early events in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> and invasiveness </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, the loss of the more proximal region 2, is highly predictive (P = 0.012) of aggressive <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastatic disease</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, two distinct <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor loci on chromosome 11p15 may contribute to <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>The fine mapping of this intriguing chromosomal region should facilitate the cloning of the target genes and provide critical clues to understanding the mechanisms that contribute to the evolution of adult and <z:e sem="disease" ids="C0278704" disease_type="Neoplastic Process" abbrv="">childhood cancers</z:e> </plain></SENT>
</text></document>